Understanding the Genetic Causes of Intellectual Disability

Intellectual disability (ID) is a condition characterized by significant limitations in both intellectual functioning and in adaptive behavior, which covers many everyday social and practical skills. While the causes are diverse, genetic factors are recognized as a primary contributor in a large proportion of cases.

The advent of next-generation sequencing has transformed the diagnostic landscape for ID. Tests like whole exome and whole genome sequencing can identify the precise genetic variant responsible for an individual’s condition, providing answers that were previously unattainable.

---

The Genetic Landscape of Intellectual Disability

The genetic basis of intellectual disability is remarkably heterogeneous. It can stem from large-scale chromosomal abnormalities, such as aneuploidies or structural rearrangements, or from variants in a single gene. To date, hundreds of genes have been implicated in ID, and this number continues to grow with ongoing research. These genes are involved in a wide array of biological processes crucial for brain development and function, including neuronal migration, synaptic function, and chromatin remodeling.

A significant portion of severe, unexplained intellectual disability is caused by de novo variants. These are spontaneous genetic changes that are not inherited from either parent.

The Diagnostic Power of Genomic Sequencing

For decades, the diagnostic pathway for ID often involved a step-wise approach with tests like karyotyping and chromosomal microarray (CMA). While these methods are effective at detecting large structural variations, they have limitations in identifying single-gene variants.

Today, whole exome sequencing (WES) and whole genome sequencing (WGS) have emerged as powerful tools that have significantly increased diagnostic rates. Studies have consistently shown that genome sequencing provides a high diagnostic yield and uncovers new etiological insights. For many clinicians, this has shifted the paradigm, establishing that genome sequencing is a sensitive first-line test for diagnosing individuals with intellectual disability.

Research shows that exome sequencing has a high diagnostic yield even in adult populations with ID. Different strategies, including approaches in specific populations like a Vietnamese intellectual disability cohort, have demonstrated the effectiveness of WES.

In some complex cases, combining methodologies can improve outcomes. For example, studies have shown that combining chromosomal microarray with clinical exome sequencing can enhance the genetic diagnosis of ID by capturing both large structural variants and single-nucleotide changes.

Clinical Implications of a Genetic Diagnosis

Receiving a specific genetic diagnosis for intellectual disability has profound benefits. A definitive diagnosis can inform prognosis, guide medical management by highlighting potential associated health issues, and open doors to condition-specific support groups and resources.

Furthermore, it provides crucial information for genetic counseling. Families can understand the inheritance pattern and the recurrence risk for future pregnancies.

* This article is educational and does not replace individualized medical advice. Diagnostic and management decisions should be made with a qualified clinician.

References

1. Ben-Mahmoud A, et al., Evaluating the Role of MAST1 as an Intellectual Disability Disease Gene: Identification of a Novel De Novo Variant in a Patient with Developmental Disabilities, 2020, DOI: 10.1007/s12031-019-01415-8, https://pubmed.ncbi.nlm.nih.gov/31721002/
2. Hamanaka K, et al., Genome sequencing provides high diagnostic yield and new etiological insights for intellectual disability and developmental delay, 2025, DOI: 10.1038/s41525-025-00521-4, https://pmc.ncbi.nlm.nih.gov/articles/PMC12381280/
3. Hoang TL, et al., Maximizing Diagnostic Yield in Intellectual Disability Through Exome Sequencing: Genotype-Phenotype Insights in a Vietnamese Cohort, 2025, DOI: 10.3390/diagnostics15222821, https://pmc.ncbi.nlm.nih.gov/articles/PMC12651281/
4. Kim J, et al., Combining chromosomal microarray and clinical exome sequencing for genetic diagnosis of intellectual disability, 2023, DOI: 10.1038/s41598-023-50285-z, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10739828/
5. Lindstrand A, et al., Genome sequencing is a sensitive first-line test to diagnose individuals with intellectual disability, 2022, DOI: 10.1016/j.gim.2022.07.022, https://pubmed.ncbi.nlm.nih.gov/36066546/
6. Maulik PK, et al., Prevalence of intellectual disability: a meta-analysis of population-based studies, 2011, DOI: 10.1016/j.ridd.2010.12.018, https://pubmed.ncbi.nlm.nih.gov/21236634/
7. Nair R, et al., Significant regional inequalities in the prevalence of intellectual disability and trends from 1990 to 2019: a systematic analysis of GBD 2019, 2022, DOI: 10.1017/S2045796022000701, https://pubmed.ncbi.nlm.nih.gov/36539341/
8. Olusanya BO, et al., Global Burden of Childhood Epilepsy, Intellectual Disability, and Sensory Impairments, 2020, DOI: 10.1542/peds.2019-2623, https://pmc.ncbi.nlm.nih.gov/articles/PMC7613313/
9. Pande S, et al., De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from India, 2023, DOI: 10.1038/s41431-023-01513-7, https://pmc.ncbi.nlm.nih.gov/articles/PMC7616498/
10. Sabo A, et al., Community-based recruitment and exome sequencing indicates high diagnostic yield in adults with intellectual disability, 2020, DOI: 10.1002/mgg3.1439, https://pmc.ncbi.nlm.nih.gov/articles/PMC7549560/
11. Wang J, et al., The diagnostic yield of intellectual disability: combined whole genome low-coverage sequencing and medical exome sequencing, 2020, DOI: 10.1186/s12920-020-0726-x, https://pmc.ncbi.nlm.nih.gov/articles/PMC7236547/